Thymosin Alpha-1 10mg

Description

Thymosin Alpha-1 10mg, documented for laboratory review

Purity Collective supplies Thymosin Alpha-1 10mg in a lyophilized vial for qualified laboratory research. This listing brings the product identity, stated quantity, SKU and available analytical records into one review path before checkout.

Analytical documents should be read as sample-specific records. Confirm the compound, lot identifiers, method, dates, specification fields and reported results in the full documents before making an internal procurement or acceptance decision.

Product details

Available analytical documents

Open the Thymosin Alpha-1 10mg UPLC/MS report and the Thymosin Alpha-1 endotoxin report to review the complete records. Purity Collective’s guide to reading a peptide COA explains how to compare identity, lot, method, date, specification and result fields. For identity/source context and document-boundary review, read the Thymosin Alpha-1 research records and COA review guide.

The UPLC/MS report identifies Thymosin Alpha-1 and lists lot PCCL-1947064-P. For the submitted sample, it records a measured quantity of 10.25mg against a 10mg specification and a purity result of 99.32% against a greater-than-98% specification. These values should be treated as lot-document results, not as a universal purity promise for every unit.

The separate endotoxin report identifies lot PCCL-1947064-E and records a result below 0.05 EU/mL. It does not print an endotoxin acceptance specification. Both documents display an analysis date of May 4, 2026 and a received date of May 9, 2026, meaning the stated analysis date is earlier than the stated received date. The reports do not establish sterility, safety, suitability or performance.

Why Purity Collective presents the full record

Qualified sourcing is strongest when catalog claims stay separate from sample-specific analytical results. Purity Collective keeps the product identity, vial format and document links visible so laboratories can review the listing against their own supplier-qualification and acceptance process.

Before you order

• Confirm that Thymosin Alpha-1, the 10mg listed quantity and SKU PC-THYMOSIN-ALPHA-1-10MG match the procurement request.
• Review both reports in full, including their separate lot identifiers, methods, dates, specifications and results.
• Note the 10.25mg measured quantity, the 99.32% purity result, the missing printed endotoxin acceptance specification and the displayed date chronology.
• Apply your laboratory’s own supplier-qualification, acceptance, storage and handling procedures.

Thymosin Alpha-1 10mg FAQs

What is included in this Thymosin Alpha-1 10mg listing?

The listing identifies Thymosin Alpha-1 with a stated quantity of 10mg, supplied in a lyophilized vial under SKU PC-THYMOSIN-ALPHA-1-10MG for qualified laboratory research.

Which analytical documents are available?

The page links directly to a two-page UPLC/MS report and a separate endotoxin report. Each document should be reviewed as a complete record, including its compound, lot, method, dates, specification fields and results.

What does the UPLC/MS report show?

For submitted lot PCCL-1947064-P, the report records a measured quantity of 10.25mg and a purity result of 99.32%. These are sample-specific results, not universal guarantees.

What limitation applies to the endotoxin report?

The endotoxin report records a result below 0.05 EU/mL, but it does not print an acceptance specification. It should not be read as a sterility, safety or suitability claim.

Is Thymosin Alpha-1 10mg intended for human use?

No. This product is supplied only for qualified laboratory research and is not for human or veterinary administration. Purity Collective does not provide clinical, therapeutic, dosing or administration guidance.

Research-use notice

For qualified laboratory research only. Not for human or veterinary administration. This listing is not presented as a medicine or treatment.